Header Logo

Connection

KAREN RABIN to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Back to Details
This is a "connection" page, showing publications KAREN RABIN has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
KAREN RABIN
Connection Strength
0.141
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  1. Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial. J Clin Oncol. 2018 05 01; 36(13):1330-1338.
    View in: PubMed
    Score: 0.141
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.